| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858717 Human formin binding protein |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858715 Polynucleotide sequence for antisense agents, hybridization probes and diagnosis of diseases; anticancer agents; antiischemic agents; alzheimer's/parkinson's diseases |
| 01/12/1999 | US5858714 Human metaxin protein |
| 01/12/1999 | US5858712 CDNA encoding a LEA-motif developmental protein homologous to avian px19 |
| 01/12/1999 | US5858710 Tumor-associated kazal inhibitor-like polypeptides and encoding polynucleotides |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858707 Nucleic acids coding for polypeptides which are structurally homologous to prokaryotic nucleoside transporters; anticancer agents; antiproliferative agents; developmental disorders |
| 01/12/1999 | US5858706 Expression of carcinoscorpius rotundicauda factor C in eukaryotes |
| 01/12/1999 | US5858704 Producing high expression levels of protein which is gamma-carboxylated, properly folded and processed by encoding protein in vector, inserting vector into eukaryotic adenovirus-transformed host cell, culturing with vitamin k |
| 01/12/1999 | US5858702 Dna from salivary, lacrimal, and pulmonary tissues; therapy for cystic fibrosis/sjogrens syndrome |
| 01/12/1999 | US5858701 DNA encoding an insulin receptor substrate |
| 01/12/1999 | US5858689 Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof |
| 01/12/1999 | US5858688 Gro genes, proteins, and uses thereof |
| 01/12/1999 | US5858686 Methods for detecting tyrosine kinase-binding target proteins and identifying substances that affect SH2 phosphorylated ligand regulatory systems |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/12/1999 | US5858683 Determining presence of non-chromatin protein in biological sample (pap smears) by immunoassay or two-dimensional electrophoresis; accurate rapid diagnosis before metastasis occurs |
| 01/12/1999 | US5858681 Quantitative analysis of thymosin beta 15 in tumor sample; higher than base line level indicates increased metastatic potential |
| 01/12/1999 | US5858678 Isolated poypetides which interact with e1b 19kd protein, bcl-2 protein and/or bhrf-1 protein, all associated with cell death; alzheimers disease, spina bifida |
| 01/12/1999 | US5858677 Protein D--an IgD-binding protein of haemophilus influenzae |
| 01/12/1999 | US5858675 Double-stranded RNA-binding protein |
| 01/12/1999 | US5858674 Screening assays to identify agents that modulate cisplatin resistance |
| 01/12/1999 | US5858672 Nucleic acid fragments and corresponding peptide fragments from the caprine arthritis-encephalitis virus (CAEV) genome, and uses thereof |
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858668 Homogeneous gene probe test using a receptor directed against the label |
| 01/12/1999 | US5858665 Nucleic acid hybridization using two-stage target cyclingreaction involving probe-activator complexes and analog-anchor complexes, kits with increase sensitivity |
| 01/12/1999 | US5858661 Isolation, purification, cloned nucleic acid sequence with mutation causing protein truncation or no initiation; detecting carriers by analysis of nucleic acids isolated from patients with hereditary muscular disorders |
| 01/12/1999 | US5858660 Parallel selex |
| 01/12/1999 | US5858658 Amplification of repetive sequences in both sample and added standard nucleic acids using complemtary primers, determining total amount of heterogenous, contaminant dna, for quality control of recombinant products |
| 01/12/1999 | US5858655 Quantitative analysis by nucleic acid hybridization using oligonucleotide probes from gene; detection of breast cancer, lymphoma, squamous cell cancer and parathyroid adenoma |
| 01/12/1999 | US5858653 Reagent and method for attaching target molecules to a surface |
| 01/12/1999 | US5858650 Methods for inactivating nucleotide sequences and metal chelates for use therein |
| 01/12/1999 | US5858647 Detecting binding of purified or isolated antigen of hiv-1 subtype o virus to antibodies present in biological sample, comparing to control; diagnosis of infection, aids, and aids related complex; kits |
| 01/12/1999 | US5858646 Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein |
| 01/12/1999 | US5858367 Methods for screening for antimicrobials utilizing AarC and compositions thereof |
| 01/12/1999 | US5858366 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding |
| 01/12/1999 | US5858362 Polysaccharide-protein |
| 01/12/1999 | US5858361 Monoclonal anti-idiotypic anti-CA125 antibodies and pharmaceutical compositions containing them |
| 01/12/1999 | US5858360 Mediate embryo-endometrium adhesion; anti-trophinin antibodies for inhibition; trophinin-assisting proteins tastin, bystin, lastin for increasing binding; endometrial adenocarcinoma |
| 01/12/1999 | US5858355 Infecting in vitro cultured synovial cells with recombinant viral vector comprising dna sequence encoding interleukin-1 receptor antagonist protein linked to promoter, transplanting cells into arthritic joint space for expression |
| 01/12/1999 | US5858353 Insect viruses, sequences, insecticidal compositions and methods |
| 01/12/1999 | US5858351 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
| 01/12/1999 | US5858347 Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors |
| 01/12/1999 | CA2153896C G-csf analog compositions and methods |
| 01/12/1999 | CA2117903C Targeted cleavage of rna using eukaryotic ribonuclease and external guide sequence |
| 01/12/1999 | CA2077308C Gene expression regulatory dna |
| 01/12/1999 | CA2070503C A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 01/10/1999 | CA2237138A1 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase |
| 01/10/1999 | CA2236493A1 Mura |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/09/1999 | CA2237158A1 Human semaphorin l (h-semal) and corresponding semaphorins in other species |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000673A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 01/07/1999 | WO1999000521A1 Lyophilization of cultured human cells to preserve rna and dna |
| 01/07/1999 | WO1999000519A1 Method of mapping restriction sites in polynucleotides |
| 01/07/1999 | WO1999000518A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | WO1999000516A2 Neuronal stem cell gene |
| 01/07/1999 | WO1999000511A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000509A2 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it, and method for weeding plants |
| 01/07/1999 | WO1999000508A1 New human cathepsin |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000506A1 Dna polymerase-related factors |
| 01/07/1999 | WO1999000505A1 Use of dna encoding plastid pyruvate dehydrogenase and branched chain oxoacid dehydrogenase components to enhance polyhydroxyalkanoate biosynthesis in plants |
| 01/07/1999 | WO1999000504A1 Improved protein expression strains |
| 01/07/1999 | WO1999000503A1 Method of increasing fruit size in a plant |
| 01/07/1999 | WO1999000502A1 Seed plants characterized by delayed seed dispersal |
| 01/07/1999 | WO1999000501A1 Materials and methods relating to a plant regulatory protein |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000499A1 Human fadd-interacting protein (fip) |
| 01/07/1999 | WO1999000498A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | WO1999000497A1 Proteins capable of binding to corticotropin-releasing factor |
| 01/07/1999 | WO1999000496A1 Novel osteoclast differentiation promoting factor and its gene |
| 01/07/1999 | WO1999000495A1 Novel protein remarkably expressed in hepatic cancer, gene encoding the same, antibody thereto, and method for detecting the expression thereof |
| 01/07/1999 | WO1999000494A2 Cell activation process and reagents therefor |
| 01/07/1999 | WO1999000493A1 Tenebrio antifreeze proteins |
| 01/07/1999 | WO1999000492A1 Plant and viral promoters |
| 01/07/1999 | WO1999000488A1 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 01/07/1999 | WO1999000487A1 Methods and tissue culture media for inducing somatic embryogenesis, agrobacterium-mediated transformation and efficient regeneration of cacao plants |
| 01/07/1999 | WO1999000425A1 IMPROVED STARCH PURIFICATION BY THERMALLY TOLERANT BROAD pH RANGE PROTEOLYTIC ENZYMES |
| 01/07/1999 | WO1999000423A1 Protein that binds trail |
| 01/07/1999 | WO1999000422A1 Novel family of pheromone receptors |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000419A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 01/07/1999 | WO1999000415A1 Cardiotrophin-like cytokine |
| 01/07/1999 | WO1999000413A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 01/07/1999 | WO1999000410A2 Human extracellular matrix proteins |
| 01/07/1999 | WO1999000407A2 Improved bacillus thuringiensis toxin |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000401A1 3'-monophosphorylating oligonucleotides |
| 01/07/1999 | WO1999000168A1 One step device and process for concentration and purification of biological molecules |
| 01/07/1999 | WO1999000152A2 Biosynthetic transplant and method for the production thereof |
| 01/07/1999 | WO1999000147A1 Antigenomic oligodeoxynucleotides for treatment of infection by negative-stranded nonsegmented rna viruses |
| 01/07/1999 | WO1999000146A1 Development and use of human pancreatic cell lines |